Affordable Access

deepdyve-link
Publisher Website

The impact of interacting drugs on dispensed doses of warfarin in the Swedish population: A novel use of population based drug registers.

Authors
  • Andersson, M L
  • Lindh, J D
  • Mannheimer, B
Type
Published Article
Journal
Journal of clinical pharmacology
Publication Date
Dec 01, 2013
Volume
53
Issue
12
Pages
1322–1327
Identifiers
DOI: 10.1002/jcph.174
PMID: 24038065
Source
Medline
Keywords
License
Unknown

Abstract

To investigate the impact of interacting drugs on the dispensed doses of warfarin in the Swedish population. This was a retrospective, cross-sectional population based register study of patients being dispensed warfarin. Warfarin doses were estimated in different age groups, in men and women, and in patients using interacting drugs. The influence of interacting drugs on the dispensed warfarin dose was analyzed using multiple regression. All 143,729 patients dispensed warfarin were analyzed. The dispensed dose of warfarin was highest in patients 30-39 years old and decreased with age. Co-medication with carbamazepine, simvastatin, paracetamol, amiodarone, fluconazole, lactulose, or bezafibrate was associated with significant changes in dispensed warfarin doses, by +40%, -3.4%, -7.3%, -8.2%, -8.8%, -9.0%, and -9.7%, respectively. After adjustment for age and gender, sulfamethoxazole was also found to significantly alter the dispensed warfarin dose (-6.1%). We provide new support for the previous scarce evidence of interactions between warfarin and carbamazepine, bezafibrate, and lactulose. Initiation or discontinuation of bezafibrate or lactulose in a patient on warfarin should warrant close clinical monitoring. The marked increased warfarin requirement associated with carbamazepine use supports moving from a more conservative reactive towards a proactive strategy including preventive warfarin dose adjustments to avoid potential adverse effects.

Report this publication

Statistics

Seen <100 times